Correlation Between Software Acquisition and Microbot Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Software Acquisition and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Software Acquisition and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Software Acquisition Group and Microbot Medical, you can compare the effects of market volatilities on Software Acquisition and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Software Acquisition with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Software Acquisition and Microbot Medical.

Diversification Opportunities for Software Acquisition and Microbot Medical

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Software and Microbot is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Software Acquisition Group and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and Software Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Software Acquisition Group are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of Software Acquisition i.e., Software Acquisition and Microbot Medical go up and down completely randomly.

Pair Corralation between Software Acquisition and Microbot Medical

Assuming the 90 days horizon Software Acquisition Group is expected to generate 6.22 times more return on investment than Microbot Medical. However, Software Acquisition is 6.22 times more volatile than Microbot Medical. It trades about 0.16 of its potential returns per unit of risk. Microbot Medical is currently generating about 0.15 per unit of risk. If you would invest  1.78  in Software Acquisition Group on May 25, 2025 and sell it today you would earn a total of  0.94  from holding Software Acquisition Group or generate 52.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy51.61%
ValuesDaily Returns

Software Acquisition Group  vs.  Microbot Medical

 Performance 
       Timeline  
Software Acquisition 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Software Acquisition Group are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical and fundamental indicators, Software Acquisition showed solid returns over the last few months and may actually be approaching a breakup point.
Microbot Medical 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Software Acquisition and Microbot Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Software Acquisition and Microbot Medical

The main advantage of trading using opposite Software Acquisition and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Software Acquisition position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.
The idea behind Software Acquisition Group and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments